Apollo HealthCo, a subsidiary of Apollo Hospitals on Friday said it has entered into a binding agreement to raise equity capital of Rs 2,475 crores from private equity firm Advent International.In addition, Apollo 24/7 has entered into a framework agreement to merge Keimed Private Limited (Keimed), India’s leading wholesale pharma distributor, in a phased manner over the next 24-30 months.Advent shall invest in compulsory convertible instruments over 2 tranches to secure 12.1% stake in the merged entity, by valuing the combined entity at an enterprise value of Rs 22,481 crores.

阿波罗医院（Apollo Hospitals）的子公司阿波罗健康公司（Apollo HealthCo）周五表示，已达成一项具有约束力的协议，将从私人股本公司Advent International筹集24.75亿卢比的股本。此外，阿波罗24/7已签订框架协议，在未来24-30个月内分阶段合并印度领先的批发医药分销商Keimed Private Limited（Keimed）。通过对合并实体的企业价值评估为2248.1亿卢比，Advent将投资2部分强制性可转换工具，以获得合并实体12.1%的股份。

Apollo 24/7 is valued at an enterprise value of Rs 14,478 crores. Keimed is valued at an enterprise value of Rs 8,003 crores. Following merger, Keimed shareholders would hold a maximum of 25.7% stake in the combined entity, while AHEL would continue to remain the largest controlling shareholder with at least 59.2% stake.ET broke the story about Apollo in discussions with Advent International to acquire a minority stake in Apollo 24/7.The merger is subject to further corporate approvals to be obtained at the relevant time.“With Advent’s investment and the merger of Keimed, the combined entity will be one of the country’s leading retail health companies,' said Dr Prathap C Reddy, chairman, Apollo Hospitals Group.“The size of the merged supply chain will allow 1.4 billion Indians access to genuine medicines within 24 minutes to 24 hours, 7 days a week.

阿波罗24/7的企业价值为1447.8亿卢比。Keimed的企业价值为80.03亿卢比。合并后，Keimed股东将在合并实体中最多持有25.7%的股份，而AHEL将继续保持最大控股股东的地位，至少持有59.2%的股份。ET在与Advent International讨论收购Apollo 24/7少数股权时披露了有关Apollo的故事。该合并需要在相关时间获得进一步的公司批准。阿波罗医院集团董事长Prathap C Reddy博士说：“随着Advent的投资和Keimed的合并，合并后的实体将成为该国领先的零售保健公司之一。合并后的供应链规模将允许14亿印度人在每周7天、24分钟至24小时内获得正品药品。

The platform will continue to strengthen and evolve to deliver market-leading and curated omni-channel health offerings, and make high quality care accessible to all,” Shobana Kamineni, vice chairperson, Apollo Hospitals.Suneeta Reddy, MD of Apollo said the combined entity will deliver Rs 25,000 crores of revenue in 3 years with 7-8% EBITDA.'This inve.

该平台将继续加强和发展，以提供市场领先和精心策划的全渠道健康服务，并使所有人都能获得高质量的护理，”阿波罗医院副主席Shobana Kaminini说道。阿波罗的医学博士SuneetaReddy表示，合并后的实体将在3年内实现25亿卢比的收入，息税折旧摊销前利润为7-8%本发票。